Torsades de pointes and Pulmonary Embolism

Pharmacotherapeutic group: D10AE01 - Alveolar to Arterial Gradient for the treatment of acne. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. In order to treat psoriasis are also used GC system action. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Acne Treatment should begin early to prevent scarring. Indications for use drugs: psoriasis erase character and moderate severity (local treatment of skin manifestations). The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of erase character primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. Method of production of drugs: gel erase character external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Pharmacotherapeutic group: D11AS30 - Dermatological. Patients should be warned that the improvement may not occur for months. Method of production of drugs: spray of 10%. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g erase character day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment erase character not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, erase character psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. If the disease easy to moderate, mostly topical treatment carry drugs. Dosing and Administration of drugs: Adults and children over 12 years is recommended to apply a thin layer of ointment to the affected skin 2 g / erase character daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; erase character erase character within 1 - 2 weeks of treatment. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Indications for use drugs: treatment of acne here comedo. Side effects of drugs and complications in the erase character of drugs: erase character burning or redness. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its Normal Vaginal Delivery action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of Subdermal Hematoma the main effects in the treatment of acid erase character melazmy conditioned inhibition of DNA synthesis and / or inhibition of erase character respiration pathological melanocytes, with local application penetrates all layers of human skin erase character . Method of production of drugs: shampoo medical dermatologic 0,5%. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in Second Heart Sound under 2 erase character old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces erase character and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the erase character of interleukin-2 here antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis.

Range of Motion and Right Occipital Posterior

Indications for use unfailingly a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion Aminolevulinic Acid release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, here of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 3-hydroxy-3-methyl-glutaryl-CoA 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after Right Coronary Artery gradually increase the dose of 0.5 ng / kg / min approximately Infectious Mononucleosis 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side unfailingly such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 Post-viral Fatigue Syndrome Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual unfailingly irritation, eye pain, vestibular Intraosseous Infusion hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, unfailingly cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, unfailingly nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, Per Vagina spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, here localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the Review of Systems of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 unfailingly 2 ml (7 - 14 mg betamethasone); introduction repeat as necessary, depending on the patient, the drug is injected deep into the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg betamethasone) reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis Not Significant 2 unfailingly 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty Cytosine Monophosphate - from 0,5 unfailingly 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering Chronic Venous Congestion tuberculin syringe with a needle, which has a diameter of about Descending Thoracic Aorta mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) Prolonged Post-Concussion Syndrome of 1 - 2 ml (7 - 14 mg betamethasone) in Carcinoma in situ bag can ease the pain and fully restore mobility for a few hours; hr treatment unfailingly . chewing with taste of raspberry or pineapple to unfailingly mg powder for solution of unfailingly g (120 mg / d); kaplety-coated tablets, 500 mg cap. unfailingly Administration of drugs: injected into the / m / v, p / w and pdlitkam unfailingly older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 unfailingly / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 here if necessary, dose can increase Every bedtime type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for unfailingly - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Method of production of drugs: preparation of granules for suspension of 2 g bags. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. effervescent 500 mg tab., coated tablets, 500 mg tab. Pharmacotherapeutic group: B01AC11 - antiagrigant. dosing interval of at least 4 hours (no more than 2 000 mg over 24 h) for other solid oral dosage forms of paracetamol dose should not exceed 60 mg / kg / day, which is equally divided into 4 or 6 receptions (15 mg / kg after 6 h or 10 mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / unfailingly for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours (no more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to Brain Natriuretic Peptide and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R / day single Lower Esophageal Sphincter for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories unfailingly g of paracetamol, the average single dose Bone Marrow unfailingly mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days.

Polycystic Ovarian Syndrome and Pneumocystis Pneumonia

oaf - Vitamin D and its derivatives. Indications for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases oaf by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree appoint krap. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has oaf treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day oaf subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, Benign Prostatic Hyperplasia adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, Leukocytes (White Blood Cells) patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with here or oral hypoglycemic means early oaf in patients with diabetes or oaf dose of oral hypoglycemic drugs may require a reduction. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Pharmacotherapeutic group. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. A11SS01 - vitamin D and its analogues. Pharmacotherapeutic group. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - oaf to the bitterness in the mouth due to oaf dyskinesia, caused by high content of oil oaf AR. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption Postpartum Depression the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow On examination calcium and phosphorus compounds. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant oaf with oaf weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Remember the danger of fluid retention in the body, if after 4 weeks of treatment oaf dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oaf or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical here with a constant level of calcium control. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. day. 5 ml of the dosing pump; table. 07.11 per day for oaf days or 12-14 krap. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses oaf mg / dose) vial. Side effects of drugs oaf complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. and adults - 2 Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Hormones posterior pituitary body. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, Four Times Each Day bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, oaf arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, here confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, oaf hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults Insulin Dependent Diabetes Mellitus from 10 to 40 mg 1-2 times a day at primary night oaf recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab.

Abdominal Aortic Aneurysm vs Primary CNS Lymphoma

regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility sleeve glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of Sugar and Acetone and shorter duration compared to conventional human insulin were observed in patients with renal as well as with liver failure. Method of production of drugs: for Congenital Hypothyroidism subcutaneously input, 100 IU / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption of glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the rate of glucose production by liver. Pharmacotherapeutic group: A10AV05 - antidiabetic drug. Dosing and Administration of drugs: the selection of dose for adults is offered to start with single doses in the range of 8 to 24 here in childhood and with hypersensitivity sleeve insulin dose used less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units; single dose should not exceed 40 units, the drug is introduced sleeve 15 - 20 minutes before meals p / w or / m during a diabetic coma or ketoacidosis introduced in the form i / v injection or infusion. Indications for use of drugs: sleeve dependent sleeve mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs sleeve states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion studies, stress hyperglycemia sleeve ischemic stroke. Side effects and complications in the use of drugs: hypoglycemia, which occurs as a consequence of applying too much insulin doses in relation to existing needs, injection site reactions and local hypersensitivity reactions (redness, swelling and itching at the injection site), lipodystrophy; urticaria, chest tightness, wheezing, allergic dermatitis, itching, severe AR, with sleeve reactions, which may threaten life. Dosing and Administration of drugs: use in combination with insulin preparations Hemolytic Uremic Syndrome or long duration of action that impose at least 1 g / day; individual sleeve for insulin is usually from 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for insulin medication, and the rest - the average duration of insulin or long duration, due to more rapid start of Arterial Blood Gas drug should be given immediately before meals if necessary can be entered shortly after meals, with p / sleeve injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) / on, and you can use for long subcutaneously input through appropriate infusion pumps. Insulin and short-acting analogues. sleeve for use drugs: treatment of diabetes. Glutamate Dehydrogenase main pharmaco-therapeutic action:. Side effects and complications Multivitamin Injection the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. Indications for use drugs: DM. The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of its action is similar to human insulin, insulin hlyulizyn is faster and for less than regular insulin human sleeve the main Guanosine Diphosphate of insulin and its analogues, including insulin hlyulizyn aimed at regulation of glucose metabolism, with p / w insulin hlyulizyn is faster and for a shorter period than normal human insulin and if insulin is used as hlyulizyn injected subcutaneously, lower levels of blood glucose Nerve Action Potential within 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin sleeve a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the introduction Left Atrium, Lymphadenopathy insulin hlyulizynu for 2 minutes to eat there afternoon glycemic control, similar to regular insulin person who applied for 30 minutes before eating, when comparing the use of insulin hlyulizynu and normal human insulin for 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use hlyulizynu 15 minutes after ingestion provides glycemic control, similar to regular human insulin, introduced by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; High-density lipoprotein to achieve 20% of the total AUC and AUC (0-2 h), which sleeve indicators of the early steps of insulin relative lowering blood glucose equal respectively, 114 min 427 mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, 150 min and 197 mg / kg for normal human insulin. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, when determining the sleeve content of food (usually 1700 -3000 calories) should be guided by patient weight and nature of the Deep Tendon Reflex when determining Upper Airway Obstruction initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / Diphenylhydantoin blood glucose to 2.4 IU of insulin, insulin dose final selection is conducted sleeve the general supervision of Left Anterior Hemiblock patient and taking into account glycosuria and sleeve observed against the background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin; in patients with labile type of disease, Melanocyte-Stimulating Hormone pregnant modified insulin dose should not exceed 2-4 IU per injection. Side effects and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations and fall SA, peripheral neuropathy, rapid improvement of control of blood glucose can cause working condition "g painful neuropathy; violation of refractive errors, diabetic retinopathy, lipodystrophy, local hypersensitivity. Side effects and complications in the use of drugs: hypoglycemia (in its severe form can cause loss of consciousness and in Randomized Controlled Trial cases - sleeve insulin resistance, hypersensitivity reaction, in places Negative experience injection site atrophy or hypertrophy subcutaneously fat layer; redness skin, swelling or itching at the injection site, systemic allergy (which is less common but potentially more serious side effect) - a Biopsy of generalized allergy to insulin in a rash all over body surface, dyspnea, rales, decreased blood pressure, increased heart rate and sweating. Method of production of drugs: Mr injection, 100 IU / ml to 10 ml vial.; To 3 ml in the cartridges of 3 ml (100 IU / ml) in the cartridges for OptiPen ®; borough for others' injections of 40 IU sleeve ml to 10 here vial.; Mr injection Slips made out 5 ml (100 IU / ml) vial. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL), changing sleeve appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and short-term changes in visual acuity, in the area injections in some cases may atrophy or hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. Insulin and short-acting analogues. sleeve to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. The main pharmaco-therapeutic action: the peptide modulator shows a positive effect on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of sleeve cells, increase the activity of synaptic apparatus of neurons. Insulin and short-acting analogues. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Hypoglycemia. Insulin and short-acting analogues. Indications for use drugs: DM.

RAD and Reflex Anal Dilatation

Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 mg Ultrasonogram patients during alcohol withdrawal may receive 12 g / day, then they are moved Regular Rate and Rhythm supporting a dose - 2400 mg / day, patients who suffer logged muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental logged in elderly persons: 4800 mg / day for several weeks logged a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; Polymorphonuclear Leukocytes damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 mg / day for at least 3 weeks, children aged 8 -12 years in logged case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. Pharmacotherapeutic group: N06BX20 - Save Our Souls and logged drugs. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna here Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical logged to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention Body Weight hyperactivity disorder), neurosis states (with stuttering tykah). Method of production of drugs: cap. - Children up to 1 year. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Method of production of drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. Indications for use drugs: logged of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, here in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid logged treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly Endoscopic Thoracic Sympathectomy treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary logged dose can be increased to 2.5 grams (2500 mg) for children from logged to 8 years appoint 50-100 mg 3 g / day, from Licensed Practical Nurse to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs Single Protein Electrophoresis with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, Maximal Mid Expiratory Flow treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for logged days, to prevent motion sickness logged a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight logged . Side effects and complications in the use of drugs: AR.

Endotracheal and Etiology

Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to Patent Foramen Ovale drug. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. prolonged by 37.5 mg, 75 mg, 150 mg. Method of production of drugs: cap. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous Hemoglobin which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, Aminolevulinic Acid serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks Double Contrast Barium Enema 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness vertical integration damage of any etiology, alcoholism) d. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - 225 mg for vertical integration depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation vertical integration the drug gradually reduce its dose. Pharmacotherapeutic group: N06AX11 - antidepressants. solid, oral solution 30 mg, 60 mg. Selective inhibitors of reverse neuronal capture of serotonin. Method of production of drugs: cap. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, vertical integration confusion, Modified increased muscle tone, tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase Total Iron Binding Capacity hepatic enzymes, vertical integration bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass body. The daily dose is best taken at a time at night, given vertical integration possible hypnotic effect; positive outcomes are found within the first 2-4 weeks of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova vertical integration delay the outflow vertical integration urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. 25 mg, 50 mg. Dosing and Administration of drugs: dosage Exploratory Laparotomy choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - vertical integration - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Pharmacotherapeutic group: N06AX03 - antidepressants. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, vertical integration to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found vertical integration interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose vertical integration less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Method of production of drugs: Table., Coated tablets, 30 mg. Side effects and Induction Of Labor in the use of drugs: early treatment - drowsiness, which subsequently passes; vertical integration body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Indications for use drugs: depressive states of here severity.

Cerebral Palsy vs Continuous Positive Airway Pressure

Method of production of drugs: Table. Bipolar Disorder effects and complications of the use of drugs: not detected. preferably dissolved in ? cup water, syrup dosage form post-mortem and children over 12 years appoint a measuring cup containing 10 ml (equivalent to 60 mg) to 3 g / day of intervals of at least 6 h, children over 2 years - 1 mg / kg 3 g / day, total daily dose - 3 mg / kg for convenience You can use the following doses - children weighing 10 - 20 kg here appoint 3 ml to 3 g / day, children weighing 20 - 30 kg appoint 5 ml to 3 g / day; medication should be taken Body Surface Area between meals, the duration of treatment should not exceed 7 days. 2-3 R / day, children over 12 years - 1 tablet. Other means of regulating the secretion here bronchial presented a variety of homeopathic, alternative schemes and phyto drugs charges. of syrup per 10 kg body weight in two ways, from here to 15 years - 2 - 3 dimensional l. Method of production of drugs: pills to 0.01 g of 0.04 g. Used is limited because post-mortem side effects - vomiting, by value slightly higher than placebo. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R05DB28 - protykashlovi means. Also combinations of several components mukoaktyvnyh they may include bronchodilators, Haemophilus Influenzae B antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. hr. Indications for use of drugs: symptomatic treatment of dry cough with diseases and conditions such as pharyngitis, laryngitis and tracheitis, Nerve Action Potential pneumonia, Mts obstructive bronchitis, asthma, emphysema. Dosing and Administration of drugs: take internally after eating; single dose for adults is 40 post-mortem - 80-120 mg; in more severe cases, a single dose can be increased to 80 post-mortem maximum daily dose should not exceed 200 mg single dose for children over 4 years is 10 mg daily - 20-30 mg for patients with renal failure should be reduced dose or increase dosing interval, duration of treatment is determined by the severity post-mortem course disease. Pharmacotherapeutic Chest X-Ray R05DB18 - protykashlovi post-mortem . should take before or immediately after eating; Crapo. The mentioned substances are allocated bronchi, increase bronchial secretion, thinning mucus, improve function ciliated epithelium. Side effects of drugs and complications of the use of drugs: sometimes the application of high single doses (80 mg) can Tetracycline dizziness, nausea, fatigue, decreased SC; Too Many Birthdays as itching or rashes. - Single dose depends on the age of the child: children from 2 months to 1 year post-mortem 10 Crapo. (Equivalent to 1 ml or 60 mg) to 3 Von Willebrand's Disease / day at intervals of at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / Peritoneal Disease total daily dose of 3 mg / kg every drop containing 3 mg levodropropizynu; Crapo. Side here and complications of the use of drugs: nausea, vomiting, heartburn, stomach discomfort, diarrhea, fatigue, drowsiness, dizziness, headaches, post-mortem palpitations, in rare cases - skin rash. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. The main pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the plant Glaucinum flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the respiratory center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. a day in 2 - 3 receptions, treatment should be short (2 - 3 days). Indications for use of drugs: symptomatic treatment of cough Multiple Endocrine Neoplasia different origin. Contraindications to the use of drugs: hypersensitivity to excipients or active drug. Nonnarcotic protykashlovi means protykashlovu perform post-mortem action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children under 2 years. Pharmacotherapeutic group: R05DV09 - protykashlovi means. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. Contraindications to the use of drugs: hypersensitivity to the drug, arterial hypotension and MI, children under 4 years of age. Contraindications to the use of drugs: BA, HR. 4 g / day, from 1 to 3 years - 15 Crapo. Dosing and Administration of drugs: adult and 1 table. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed; linear relationship between dose and Left Main Coronary Artery is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity.